A complete application in a minute
Tailored resume and cover letter, ready to send.
Neurocrine Biosciences is seeking a PhD-level leader to oversee Safety Pharmacology and Toxicology in discovery and development programs. You will collaborate with preclinical teams to define development strategies, ensure high-quality data handling, and present findings to management and health authorities as trials progress from First in Human to phase 3.
You will mentor junior staff, drive strategic toxicology direction, and ensure adherence to regulatory standards across programs and
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life‑changing treatments for patients with under‑addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, classic congenital adrenal hyperplasia, hyperphagia in Prader‑Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com , and follow the company on LinkedIn , X , Facebook and YouTube . ( *in collaboration with AbbVie )
Responsible for overseeing the design, conduct, interpretation and reporting of Safety Pharmacology and Toxicology studies for assigned Discovery and Development programs. Collaborates with preclinical colleagues to develop overall Safety Pharmacology and Toxicology Development Strategies for assigned programs. Represent Preclinical Development on Discovery and Development teams and regularly interface with internal and external colleagues to ensure timely and accurate dissemination of Safety Pharmacology and Toxicology findings. Authors and reviews regulatory submissions and meets with Health Authorities to support clinical trials of Neurocrine development candidates from initiation of First in Human to phase 3 clinical trials and marketing applications. _
A